Open Access
Issue
Wuhan Univ. J. Nat. Sci.
Volume 30, Number 6, December 2025
Page(s) 613 - 628
DOI https://doi.org/10.1051/wujns/2025306613
Published online 09 January 2026
  1. Duan J Y, Wang C J, Liu D W, et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: A cross-sectional survey[J]. Scientific Reports, 2019, 9: 10408. [Google Scholar]
  2. Tuttle K R, Agarwal R, Alpers C E, et al. Molecular mechanisms and therapeutic targets for diabetic kidney disease[J]. Kidney International, 2022, 102(2): 248-260. [Google Scholar]
  3. Neuen B L, Heerspink H J L, Vart P, et al. Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal MRA compared with conventional care in patients with type 2 diabetes and albuminuria[J]. Circulation, 2024, 149(6): 450-462. [Google Scholar]
  4. Ishibashi T, Morita S, Furuta H, et al. Renoprotective potential of concomittant medications with SGLT2 inhibitors and renin-angiotensin system inhibitors in diabetic nephropathy without albuminuria: A retrospective cohort study[J]. Scientific Reports, 2023, 13: 16373. [Google Scholar]
  5. Hidalgo A, Libby P, Soehnlein O, et al. Neutrophil extracellular traps: From physiology to pathology[J]. Cardiovascular Research, 2022, 118(13): 2737-2753. [Google Scholar]
  6. O'Neil L J, Oliveira C B, Wang X H, et al. Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis[J]. Annals of the Rheumatic Diseases, 2023, 82(5): 630-638. [Google Scholar]
  7. Zhang H, Wang Y, Qu M D, et al. Neutrophil, neutrophil extracellular traps and endothelial cell dysfunction in sepsis[J]. Clinical and Translational Medicine, 2023, 13(1): e1170. [Google Scholar]
  8. Gupta A, Singh K, Fatima S, et al. Neutrophil extracellular traps promote NLRP3 inflammasome activation and glomerular endothelial dysfunction in diabetic kidney disease[J]. Nutrients, 2022, 14(14): 2965. [Google Scholar]
  9. Haapalainen A M, Daddali R, Hallman M, et al. Human CPPED1 belongs to calcineurin-like metallophosphoesterase superfamily and dephosphorylates PI3K-AKT pathway component PAK4[J]. Journal of Cellular and Molecular Medicine, 2021, 25(13): 6304-6317. [Google Scholar]
  10. Vaittinen M, Kaminska D, Käkelä P, et al. Downregulation of CPPED1 expression improves glucose metabolism in vitro in adipocytes[J]. Diabetes, 2013, 62(11): 3747-3750. [Google Scholar]
  11. Leek J T, Johnson W E, Parker H S, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experimentsFree[J]. Bioinformatics, 2012, 28(6): 882-883. [Google Scholar]
  12. Zhang Y, Guo L P, Dai Q C, et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps[J]. Journal for Immunotherapy of Cancer, 2022, 10(6): e004210. [Google Scholar]
  13. Ritchie M E, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies[J]. Nucleic Acids Research, 2015, 43(7): e47. [Google Scholar]
  14. Subramanian A, Tamayo P, Mootha V K, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles[J]. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(43): 15545-15550. [Google Scholar]
  15. Liberzon A, Birger C, Thorvaldsdóttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection[J]. Cell Systems, 2015, 1(6): 417-425. [Google Scholar]
  16. Liberzon A, Subramanian A, Pinchback R, et al. Molecular Signatures Database (MSigDB) 3.0[J]. Bioinformatics, 2011, 27(12): 1739-1740. [Google Scholar]
  17. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes[J]. Nucleic Acids Research, 2000, 28(1): 27-30. [Google Scholar]
  18. Yu G C, Wang L G, Han Y Y, et al. clusterProfiler: An R package for comparing biological themes among gene clusters[J]. Omics, 2012, 16(5): 284-287. [CrossRef] [PubMed] [Google Scholar]
  19. Robin X, Turck N, Hainard A, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves[J]. BMC Bioinformatics, 2011, 12(1): 77. [CrossRef] [PubMed] [Google Scholar]
  20. Wu S, Lv X K, Li Y L, et al. Integrated machine learning and single-sample gene set enrichment analysis identifies a TGF-beta signaling pathway derived score in headneck squamous cell carcinoma[J]. Journal of Oncology, 2022, 2022: 3140263. [Google Scholar]
  21. Ru B B, Wong C N, Tong Y, et al. TISIDB: An integrated repository portal for tumor-immune system interactionsFree[J]. Bioinformatics, 2019, 35(20): 4200-4202. [Google Scholar]
  22. Ito K, Murphy D. Application of ggplot2 to pharmacometric graphics[J]. CPT: Pharmacometrics & Systems Pharmacology, 2013, 2(10): 79. [Google Scholar]
  23. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004, 303(5663): 1532-1535. [CrossRef] [PubMed] [Google Scholar]
  24. Dowey R, Iqbal A, Heller S R, et al. A bittersweet response to infection in diabetes; targeting neutrophils to modify inflammation and improve host immunity[J]. Frontiers in Immunology, 2021, 12: 678771. [Google Scholar]
  25. Bhat A A, Nisar S, Singh M, et al. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy[J]. Cancer Communications, 2022, 42(8): 689-715. [Google Scholar]
  26. Galozzi P, Bindoli S, Doria A, et al. The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities[J]. Autoimmunity Reviews, 2021, 20(4): 102785. [Google Scholar]
  27. Xue X, Liu X H, Lu C L, et al. Chinese patent herbal medicine Huaiqihuang for Henoch-Schonlein purpura nephritis in children: A systematic review of randomized controlled trials[J]. BMC Complementary Medicine and Therapies, 2021, 21(1): 278. [Google Scholar]
  28. Zhao H K, Wu L, Yan G F, et al. Inflammation and tumor progression: Signaling pathways and targeted intervention[J]. Signal Transduction and Targeted Therapy, 2021, 6: 263. [Google Scholar]
  29. Guan Y K, Peiffer B, Feng D C, et al. IL-8+ neutrophils drive inexorable inflammation in severe alcohol-associated hepatitis[J]. The Journal of Clinical Investigation, 2024, 134(9): e178616. [Google Scholar]
  30. Hughes C E, Nibbs R J B. A guide to chemokines and their receptors[J]. The FEBS Journal, 2018, 285(16): 2944-2971. [Google Scholar]
  31. Serra H M, Baena-Cagnani C E, Eberhard Y. Is secondary lymphoid-organ chemokine (SLC/CCL21) much more than a constitutive chemokine?[J]. Allergy, 2004, 59(11): 1219-1223. [Google Scholar]
  32. Liu Y S, Li Y, Liu Y X, et al. Investigation of the shared biomarkers in heterotopic ossification between ossification of the ligamentum flavum and ankylosing spondylitis[J]. Global Spine Journal, 2025, 15(1): 161-174. [Google Scholar]
  33. Gierlikowska B, Stachura A, Gierlikowski W, et al. Phagocytosis, degranulation and extracellular traps release by neutrophils-the current knowledge, pharmacological modulation and future prospects[J]. Frontiers in Pharmacology, 2021, 12: 666732. [Google Scholar]
  34. Metzemaekers M, Gouwy M, Proost P. Neutrophil chemoattractant receptors in health and disease: Double-edged swords[J]. Cellular & Molecular Immunology, 2020, 17(5): 433-450. [Google Scholar]
  35. Mayadas T N, Cullere X, Lowell C A. The multifaceted functions of neutrophils[J]. Annual Review of Pathology, 2014, 9: 181-218. [Google Scholar]
  36. Yarchoan M, Ho W J, Mohan A, et al. Effects of B cell-activating factor on tumor immunity[J]. JCI Insight, 2020, 5(10): e136417. [Google Scholar]
  37. Yeo S C, Barratt J. The contribution of a proliferation-inducing ligand (APRIL) and other TNF superfamily members in pathogenesis and progression of IgA nephropathy[J]. Clinical Kidney Journal, 2023, 16: 9-18. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.